Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 6/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.35 |
| ▸ | FABP7 | O15540 | 1/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asparagine SCHEMBL2902137 | 0.96 | MC4R (0.35) | MC4RTACR1FABP7FABP5PIN1 | |
| SCHEMBL2906513 | 0.88 | FABP5 (0.42) | FABP7FABP5SLC6A4SLC6A3 | |
| SCHEMBL1675974 | 0.77 | FABP5 (0.50) | MC4RTACR1FABP7FABP5SLC6A4 | |
| SCHEMBL1675971 | 0.77 | FABP5 (0.50) | MC4RTACR1FABP7FABP5SLC6A4 | |
| SCHEMBL31582094 | 0.74 | FABP5 (0.43) | FABP7FABP5 | |
| SCHEMBL31524267 | 0.74 | FABP5 (0.43) | FABP7FABP5 | |
| SCHEMBL4040012 | 0.70 | FABP5 (0.45) | FABP7FABP5 | |
| SCHEMBL3423135 | 0.70 | FABP5 (0.47) | FABP7FABP5 | |
| SCHEMBL4050272 | 0.70 | FABP5 (0.47) | FABP7FABP5 | |
| SCHEMBL30686169 | 0.70 | FABP5 (0.47) | FABP7FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1157040-A1 | LOW MOLECULAR WEIGHT PEPTIDE DERIVATIVES AS INHIBITORS OF THE LAMININ/NIDOGEN INTERACTION | Aventis Pharma Deutschland GmbH (DE) | 2001-11-28 | — | — | EP | disclosed |
| WO-2000052051-A1 | LOW MOLECULAR WEIGHT PEPTIDE DERIVATIVES AS INHIBITORS OF THE LAMININ/NIDOGEN INTERACTION | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-09-08 | — | — | WO | disclosed |